Abstract
The chemistry of aptamers is largely limited to natural nucleotides, and although modifications of nucleic acids can enhance target aptamer affinity, there has not yet been a technology for selecting the right modifications in the right locations out of the vast number of possibilities, because enzymatic amplification does not transmit sequence-specific modification information. Here we show the first method for the selection of specific nucleoside modifications that increase aptamer binding efficacy, using the oncoprotein EGFR as a model target. Using fluorescence-activated bead sorting (FABS), we have successfully selected optimized aptamers from a library of >65 000 variations. Hits were identified by tandem mass spectrometry and validated by using an EGFR binding assay and computational docking studies. Our results provide proof of concept for this novel strategy for the selection of chemically optimised aptamers and offer a new method for rapidly synthesising and screening large aptamer libraries to accelerate diagnostic and drug discovery.
Original language | English |
---|---|
Pages (from-to) | 9517-9525 |
Number of pages | 9 |
Journal | Chemical Science |
Volume | 14 |
Issue number | 35 |
DOIs | |
Publication status | Published - 11 Aug 2023 |
Externally published | Yes |
Funding
This project was supported by the University of Kent and Centauri Therapeutics. We thank Kevin Howland for his assistance with the mass spectrometry technology.
Funders | Funder number |
---|---|
University of Kent and Centauri Therapeutics |
ASJC Scopus subject areas
- General Chemistry